{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:25:30Z","timestamp":1791321930482,"version":"4.3.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:p>Hypertension is the leading cause of cardiovascular diseases, and angiotensin II is one of the major components of the mechanisms that contribute to the development of hypertension. However, the precise mechanisms for the development of hypertension are unknown. Our recent study showing that angiotensin II\u2013induced vascular smooth muscle cell growth depends on cytochrome P450 1B1 led us to investigate its contribution to hypertension caused by this peptide. Angiotensin II was infused via miniosmotic pump into rats (150 ng\/kg per minute) or mice (1000 \u03bcg\/kg per day) for 13 days resulting in increased blood pressure, increased cardiac and vascular hypertrophy, increased vascular reactivity to vasoconstrictor agents, increased vascular reactive oxygen species production, and endothelial dysfunction in both species. The increase in blood pressure and associated pathophysiological changes were minimized by the cytochrome P450 1B1 inhibitor 2,3\u2032,4,5\u2032-tetramethoxystilbene in both species and was markedly reduced in<jats:italic>Cyp1b1<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup>mice. These data suggest that cytochrome P450 1B1 contributes to angiotensin II\u2013induced hypertension and associated pathophysiological changes. Moreover, 2,3\u2032,4,5\u2032-tetramethoxystilbene, which prevents both cytochrome P450 1B1\u2013dependent and \u2013independent components of angiotensin II\u2013induced hypertension and inhibits associated pathophysiological changes could be clinically useful in the treatment of hypertension and associated cardiovascular and inflammatory diseases.<\/jats:p>","DOI":"10.1161\/hypertensionaha.110.154518","type":"journal-article","created":{"date-parts":[[2010,8,31]],"date-time":"2010-08-31T02:48:16Z","timestamp":1283222896000},"page":"667-674","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":62,"title":["Cytochrome P450 1B1 Contributes to Angiotensin II\u2013Induced Hypertension and Associated Pathophysiology"],"prefix":"10.1161","volume":"56","author":[{"given":"Brett L.","family":"Jennings","sequence":"first","affiliation":[{"name":"From the Department of Pharmacology (B.L.J., S.S.-F., A.M.E., K.D., N.F., X.R.F., K.U.M.), College of Medicine, University of Tennessee Health Science Center, Memphis, Tenn; Laboratory of Metabolism (F.J.G.), National Cancer Institute, Bethesda, Md."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyhan","family":"Sahan-Firat","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology (B.L.J., S.S.-F., A.M.E., K.D., N.F., X.R.F., K.U.M.), College of Medicine, University of Tennessee Health Science Center, Memphis, Tenn; Laboratory of Metabolism (F.J.G.), National Cancer Institute, Bethesda, Md."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Estes","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology (B.L.J., S.S.-F., A.M.E., K.D., N.F., X.R.F., K.U.M.), College of Medicine, University of Tennessee Health Science Center, Memphis, Tenn; Laboratory of Metabolism (F.J.G.), National Cancer Institute, Bethesda, Md."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanak","family":"Das","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology (B.L.J., S.S.-F., A.M.E., K.D., N.F., X.R.F., K.U.M.), College of Medicine, University of Tennessee Health Science Center, Memphis, Tenn; Laboratory of Metabolism (F.J.G.), National Cancer Institute, Bethesda, Md."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasreen","family":"Farjana","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology (B.L.J., S.S.-F., A.M.E., K.D., N.F., X.R.F., K.U.M.), College of Medicine, University of Tennessee Health Science Center, Memphis, Tenn; Laboratory of Metabolism (F.J.G.), National Cancer Institute, Bethesda, Md."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao R.","family":"Fang","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology (B.L.J., S.S.-F., A.M.E., K.D., N.F., X.R.F., K.U.M.), College of Medicine, University of Tennessee Health Science Center, Memphis, Tenn; Laboratory of Metabolism (F.J.G.), National Cancer Institute, Bethesda, Md."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology (B.L.J., S.S.-F., A.M.E., K.D., N.F., X.R.F., K.U.M.), College of Medicine, University of Tennessee Health Science Center, Memphis, Tenn; Laboratory of Metabolism (F.J.G.), National Cancer Institute, Bethesda, Md."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kafait U.","family":"Malik","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology (B.L.J., S.S.-F., A.M.E., K.D., N.F., X.R.F., K.U.M.), College of Medicine, University of Tennessee Health Science Center, Memphis, Tenn; Laboratory of Metabolism (F.J.G.), National Cancer Institute, Bethesda, Md."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_1_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.59.3.3"},{"key":"e_1_3_3_2_2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-3565(24)37208-8","volume":"284","year":"1998","unstructured":"Muthalif MM, Benter IF, Uddin MR, Harper JL, Malik KU. Signal transduction mechanisms involved in angiotensin-(1\u20137)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells. J Pharmacol Exp Ther. 1998; 284: 388\u2013398.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002192"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.21.040181.002403"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2875"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.31.1.194"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-200103000-00012"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00021.2001"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(82)90008-9"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111305200"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.23.1_suppl.i142"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.31.1.242"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1159\/000099200"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00664.2001"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1990.259.6.H1774"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.36.4.604"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.74.6.8187280"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.20.4.940"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200406000-00015"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e318046f34a"},{"key":"e_1_3_3_21_2","first-page":"2979","volume":"56","year":"1996","unstructured":"Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, Sutter TR. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 1996; 56: 2979\u20132984.","journal-title":"Cancer Res"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2004.tb03162.x"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.18.9776"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.32.8.840"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1080\/03602530600632063"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11626-998-0060-7"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvn360"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(01)00536-3"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/gen035"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.110.150029"},{"key":"e_1_3_3_31_2","first-page":"8164","volume":"61","year":"2001","unstructured":"Chun Y-J, Kim S, Kim D, Lee S-K, Guengerich FP. A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis. Cancer Res. 2001; 61: 8164\u20138170.","journal-title":"Cancer Res"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.38.6.1311"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199611000-00014"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2006.05.022"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.145326"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118623"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000163631.07205.fb"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.2001.281.1.H30"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI23378"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000043501.47934.fa"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20070657"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2079"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1136\/mp.51.3.138"},{"key":"e_1_3_3_44_2","first-page":"139","volume":"8","year":"1999","unstructured":"Spencer DL, Masten SA, Lanier KM, Yang X, Grassman JA, Miller CR, Sutter TR, Lucier GW, Walker NJ. Quantitative analysis of constitutive and 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced cytochrome P450 1B1 expression in human lymphocytes. Cancer Epidemiol Biomarkers Prev. 1999; 8: 139\u2013146.","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.110.154518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T07:42:14Z","timestamp":1740469334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.110.154518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.110.154518"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.110.154518","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"2010-04-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-08-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-08-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}